Home
McKesson

McKesson Market Share Analysis for May 2026

McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 51,000 employees.

Health > Pharmacy

Domainmckesson.uk

Year Founded1833

Employees> 10001

Annual Revenue> $1B

McKesson

McKesson (including company regionals)

mckesson.uk

See more website traffic and engagement information

McKesson Revenue up to May 2026 is > 1B

revenue generated by McKesson top domains

McKesson top domains revenue over 3 years

Revenue for McKesson top domains

mckesson.uk> 1B

See more with Sales Intelligence

McKesson Stock price in May 2026

McKesson stock is traded under the ticker #MCK. Below you can review McKesson stock performance in the past 12 months up to May 2026

Total visits to McKesson's top domains

Understand McKesson market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in McKesson's top domains

Analyze McKesson engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on McKesson's top domains

See how McKesson keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

McKesson top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by McKesson

These are the website technologies, by industry, used by McKesson top domains

Widget (3)

Twemoji

Advertising (2)

DoubleClick

Audio Video Media (2)

YouTube

Mobile (2)

Meta Viewport

More Technologies

8

See all

News & Signals from McKesson

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAurelius Group acquires McKesson group.The financial report comes as the asset management group Aurelius announced on 7 April 2022 that it had completed its acquisition of McKesson UK — LloydsPharmacy’s parent group — which was first announced in November 2021.

NewsMcKesson group sells assets to Aurelius Ag in the amount of $636M.McKesson Corporation, parent company of LloydsPharmacy, has entered an agreement to sell its UK businesses to private equity firm Aurelius for £477 million.

NewsMcKesson group launched Phesgo on May 16th '21.Recently McKesson announced that a new cancer medicine for treating women with HER2-positive breast cancer, Phesgo, will become available to suitable patients.